Skip to main content
Log in

Deletions of Chromosomes 1p and 19q are Detectable on Frozen Smears of Gliomas by FISH: Usefulness for Stereotactic Biopsies

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Among diffuse gliomas, oligodendrogliomas may account for 25% of cases. They have a better prognosis and chemosensitivity as compared to astrocytomas. Genetic studies have shown a correlation between oligodendrocyte phenotype and presence of 1p/19q deletions. In addition, these deletions are of prognostic value. The aim of the present study was to describe a new method to detect 1p/19q deletions when little tumoral material is available (stereotactic biopsies (SBs)). Since smears (cytological preparations) are routinely done for intraoperative diagnosis of gliomas, we have searched for 1p/19q deletions by FISH in a series of 30 patients with a glioma. In 14 cases, loss of heterozygosity (LOH) analysis was also performed in order to validate our method. We found that FISH analysis on frozen smears was a simple, rapid and reliable method to detect 1p/19q deletions and a good concordance was found with LOH data (85%). The main advantages of FISH analysis on frozen smears are the following. First, it requires little material and can be easily done in the case of SBs. Second, it has a higher sensitivity than LOH especially in infiltrative areas of gliomas. Third, it allows detection of a codeletion 1p/19q in a single tumor cell.

In contrast, LOH analysis is easier to interpret and can detect smaller and partial deletion whose pronostic significance remains to be defined. In conclusion, these two techniques can be used to investigate 1p/19q status in gliomas. The appropriate choice of one or other of these two techniques will depend on the specific questions that need to be answered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Reifenberger G, Kros JM, Schiffer D, Burger PC, Louis DN, Collins VP: Oligodendroglioma. In: Kleihues PK, Cavenee WK (eds) Pathology and Genetics Tumours of the Nervous System. 2nd edn., IARC Press, Lyon, 2000, pp. 56-61

    Google Scholar 

  2. Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, Graeber MB, Bauserman S, Buckner JC, Burton J, Riepe R, Tazelaar HD, Nascimento AG, Crotty T, Keeney GL, Pernicone P, Altermatt H: Oligodroglioma: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60: 248–262, 2001

    PubMed  CAS  Google Scholar 

  3. Bello MJ, Vaquero J, De Campos JM, Kusak E, Sarasa JL, Saez-Castresana J, Pestana A, Rey JA: Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 57: 172–175, 1994

    PubMed  CAS  Google Scholar 

  4. Bello MJ, Leone PE, Vaquero J, De Campos JM, Kusak ME, Sarasa JL, Pestana A, Rey JA: Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenetic events in oligodendroglial tumors. Int J Cancer 64: 207–210, 1995

    PubMed  CAS  Google Scholar 

  5. Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD: Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155: 375–386, 1999

    PubMed  CAS  Google Scholar 

  6. Rasheed BK, Wiltshire RN, Bigner SH, Bigner SH, Bigner DD: Molecular pathogenesis of malignant gliomas. Curr Opin Oncol 11: 162–167, 1999

    Article  PubMed  CAS  Google Scholar 

  7. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18: 4144–4152, 1999

    Article  PubMed  CAS  Google Scholar 

  8. Smith JS, Jenkins RB: Genetic alterations in adults diffuse glioma: occurrence, significance and prognostic implications. Front Biosci 5: 1, 2000

    CAS  Google Scholar 

  9. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311–1333, 2001

    Article  PubMed  CAS  Google Scholar 

  10. Reifenberger G, Louis DN: Oligodendroglioma: towards molecular definitions in diagnostic neuro-oncology. JNEN 62: 111–126, 2003

    CAS  Google Scholar 

  11. Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H: Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. Acta Neuropathol (Berl) 103: 267–275, 2002

    Article  CAS  Google Scholar 

  12. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473–1479, 1998

    Article  PubMed  CAS  Google Scholar 

  13. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB: Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18: 636–645, 2000

    PubMed  CAS  Google Scholar 

  14. Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov, Ramsay DA, Cairncross JG, Louis DN: Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7: 839–845, 2001

    PubMed  CAS  Google Scholar 

  15. Hoang-Xuan K, He J, Huguet S, Mokhtari K, Marie S, Kujas M, Leuraud P, Capelle L, Delattre JY, Poirier J, Broët P, Sanson M: Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology 57: 1278–1281, 2001

    PubMed  CAS  Google Scholar 

  16. Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW: Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Front Biosci 8: 1, 2003

    Google Scholar 

  17. Beuvon F, Varlet P, Fallet-Bianco C, Daumas-Duport C: Techniques des smears pour l'examen extemporané: apport en pathologie neurochirurgicale. Ann Pathol 20: 499–506, 2000

    PubMed  CAS  Google Scholar 

  18. Schmidt MC, Antweiler S, Urban N, Mueller W, Meyer-Puttlitz KB, Wiestler OD, Louis DN, Fimmers R, Von Diemling A: Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61: 321–328, 2002

    PubMed  CAS  Google Scholar 

  19. Hatanpaa KJ, Burger PC, Eshelman JR, Murphy KM, Berg KD: Molecular diagnosis of oligodendrogliomas in paraffin sections. Lab Invest 83: 419–428, 2003

    PubMed  CAS  Google Scholar 

  20. Katsetos CD, Del VL, Geddes JF, Path FR, Aldape K, Boyd JC, Legido A, Khalili K, Perentes E, Mörk SJ: Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status. J Neuropathol Exp Neurol 61: 307–320, 2002

    PubMed  CAS  Google Scholar 

  21. Herrlinger U, Felsberg J, Kuker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M: Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 52: 390–399, 2002

    Article  PubMed  CAS  Google Scholar 

  22. Kros JM, Zheng P, Dinjens WN, Alers JC: Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis. J Neuropathol Exp Neurol 61: 806–814, 2002

    PubMed  CAS  Google Scholar 

  23. Mawrin C, Lins H, Kirches WN, Schildhaus HU, Scherlach C, Kanakis D, Dietzmann: Distribution of p53 alterations in a case of gliomatosis cerebri. Hum Pathol 34: 102–106, 2003

    Article  PubMed  Google Scholar 

  24. Low M, Feiden W, Moringlane JR, Zang KD, Henn W: Detection of numerical chromosome aberrations in brain tumours by fluorescence in situ hybridization on smear preparations of small tumour biopsies. Neuropathol Appl Neurobiol 20: 432–438, 1994

    Article  PubMed  CAS  Google Scholar 

  25. Perry A, Nobori T, Ru N, Anderl K, Borell TJ, Mohapatra G, Feuerstein BG, Jenkins RB, Carson DA: Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. J Neuropathol Exp Neurol 56: 999–1008, 1997

    PubMed  CAS  Google Scholar 

  26. Walker C, Joyce K, Du Plessis D, MacHell Y, Sibson DR, Broome J: Molecular genetic analysis of archival gliomas using diagnostic smears. Neuropathol Appl Neurobiol 26: 441–447, 2000

    Article  PubMed  CAS  Google Scholar 

  27. Kosel S, Graeber MB: Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol (Berl) 88: 19–25, 1994

    Article  CAS  Google Scholar 

  28. Srinivasan M, Sedmak D, Jewell S: Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161: 1961–1971, 2002

    PubMed  CAS  Google Scholar 

  29. Jenkins RB, Curran W, Scott CB, Cairncross G: Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a National Cooperative Treatment Group. Am J Clin Oncol 24: 506–508, 2001

    Article  PubMed  CAS  Google Scholar 

  30. Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA: Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens. Mod Pathol 16: 708–715, 2003

    Article  PubMed  Google Scholar 

  31. Iuchi T, Namba H, Iwadate E, Shishikura T, Kageyama H, Nakamura Y, Ohira M, Yamaura A, Osato K, Sakiyama S, Nakagawara A: Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglioma tumors. Genes Chromosomes Cancer 35: 170–175, 2002

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bouvier, C., Roll, P., Quilichini, B. et al. Deletions of Chromosomes 1p and 19q are Detectable on Frozen Smears of Gliomas by FISH: Usefulness for Stereotactic Biopsies. J Neurooncol 68, 141–149 (2004). https://doi.org/10.1023/B:NEON.0000027758.10286.c1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:NEON.0000027758.10286.c1

Navigation